Abraham Ceesay
Director; Director, Chief Executive Officer · 8 filings · Latest: Aug 10, 2026
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Rapport Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RAPP | Abraham Ceesay | Director, Chief Executive Officer | Aug 11, 2026 | Sale | $48.01 | 28,958 | $1.4M | 486,108 | |
RAPP | Abraham Ceesay | Director, Chief Executive Officer | Aug 10, 2026 | Sale | $46.26 | 22,541 | $1.0M | 515,066 | |
RAPP | Abraham Ceesay | Director, Chief Executive Officer | Jul 27, 2026 | Sale | $42.11 | 2,210 | $93.1K | 537,607 | |
RAPP | Abraham Ceesay | Director, Chief Executive Officer | Jul 14, 2026 | Sale | $40.00 | 8,210 | $328.4K | 539,817 | |
RAPP | Abraham Ceesay | Director, Chief Executive Officer | Jun 29, 2026 | Sale | $39.83 | 8,220 | $327.4K | 548,027 | |
RAPP | Abraham N. Ceesay | — | Jun 29, 2026 | Proposed Sale | $40.39 | 99,480 | $4.0M | — | |
PCRX | Ceesay Abraham | — | Jun 12, 2026 | Proposed Sale | $23.27 | 9,039 | $210.4K | — | |
RAPP | Abraham Ceesay | Director, Chief Executive Officer | Feb 18, 2026 | Sale | $29.35 | 10,916 | $320.4K | 20,729 | |
RAPP | Abraham Ceesay | Director, Chief Executive Officer | Jan 20, 2026 | Sale | $26.11 | 10,916 | $285.1K | 25,812 | |
RAPP | THE DOROTHY CEESAY IRREVOCABLE TRUST | — | Dec 17, 2025 | Proposed Sale | $30.76 | 15,249 | $469.1K | — | |
RAPP | ABRAHAM CEESAY | — | Dec 17, 2025 | Proposed Sale | $30.76 | 17,499 | $538.3K | — | |
RAPP | ABRAHAM CEESAY | — | Sep 17, 2025 | Proposed Sale | $26.19 | 52,501 | $1.4M | — | |
RAPP | THE DOROTHY CEESAY IRREV TRUST U/ADTD 03/27/2024 | — | Sep 17, 2025 | Proposed Sale | $26.19 | 45,751 | $1.2M | — | |
PCRX | Ceesay Abraham | — | Sep 4, 2025 | Proposed Sale | $27.19 | 2,354 | $64.0K | — |